chitosan has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
El-Mehasseb, IM; El-Shafai, NM; Ibrahim, MM; Masoud, MS; Mersal, GAM; Ramadan, MS | 1 |
Abd El-Hady, BM; Ekram, B; Okasha, H; Rashdan, HRM; Salem, MM | 1 |
Al-Qahtani, SD; Alalawy, AI; Alatawi, K; El-Mehasseb, IM; El-Shafai, NM; Farrag, MA; Nada, AI | 1 |
Cao, LL; Kuang, Y; Li, MY; Wang, BN; Yang, Y; Yuan, D; Zhang, ZW | 1 |
4 other study(ies) available for chitosan and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Drug delivery of sofosbuvir drug capsulated with the β-cyclodextrin basket loaded on chitosan nanoparticle surface for anti-hepatitis C virus (HCV).
Topics: Animals; Antiviral Agents; beta-Cyclodextrins; Chitosan; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Mice; Nanoparticles; Pharmaceutical Preparations; Sofosbuvir; Treatment Outcome | 2022 |
Investigation of novel HCV therapies: Boscia angustifalia & Boscia senegalensis extracts loaded on galactosylated chitosan nanoparticles synthesized by eco-friendly method for HCV treatment.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Chitosan; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Nanoparticles | 2023 |
Spectroscopic study to verify the anti-hepatitis C virus (HCV) treatment through a delivery system of the sofosbuvir drug on chitosan and pycnogenol nanoparticles surface.
Topics: Animals; Antiviral Agents; Chitosan; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Mice; Pharmaceutical Preparations; Ribavirin; Sofosbuvir; Spectrum Analysis | 2023 |
[Investigation of HCV multi-epitope gene vaccine loaded by CTS-Fe3O4].
Topics: Animals; Chitosan; Epitopes; Female; Ferrosoferric Oxide; Hepacivirus; Hepatitis C; Humans; Magnetics; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Vaccines, DNA; Viral Hepatitis Vaccines | 2011 |